# About DSIP Research — DSIP Peptide Independent Editorial Digest > About this DSIP peptide research digest: an independent editorial project summarizing the published peer-reviewed literature on delta sleep-inducing peptide (emideltide). ## About DSIP Research DSIP Research is an independent editorial project that publishes summaries of the peer-reviewed research literature on DSIP peptide — also called delta sleep-inducing peptide or emideltide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science. The domain name "DSIP Research" is editorial positioning — it describes the subject and scope of the publication. It is not a claim about clinical services, a healthcare facility, or a medical practice. This site does not offer treatment, consultation, or prescription services of any kind. ## Why this site exists DSIP is a compound with a coherent and internally consistent published research record spanning more than four decades, a set of controlled human clinical trials, and a genuinely unresolved mechanistic mystery — no identified receptor, no identified precursor gene. That combination makes it an unusually interesting subject for an editorial research digest. The findings are worth reading. The open questions are worth documenting. The literature does not require embellishment. ## What we cover DSIP peptide mechanism of action, sleep architecture studies in humans and animals, pharmacokinetics, dosage protocols from published research, HPA axis and hormonal findings, safety data from controlled trials, and recent neuroprotection and aging work. All claims are cited to numbered references in the published peer-reviewed literature. ## What we do not cover Vendor comparisons, sourcing information, human dosing recommendations, or anything that would constitute medical advice. ## Editorial standards Every quantitative claim is cited. No finding is presented without a corresponding numbered reference. Uncertain or unresolved matters — the unknown receptor, the species-dependent GH findings, the limited scale of human trials — are stated as uncertain or unresolved. ## Affiliation DSIP Research is not affiliated with any clinical institution, pharmaceutical company, compounding pharmacy, or research vendor. --- Nine residues, twenty-five studies, one grid — the DSIP peptide research record indexed by finding, not by vendor.